LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International NV, (NASDAQ:OFIX) announced today that Jerry
Benjamin, Orthofix Board member and former General Partner of Advent
Venture Partners passed away unexpectedly on February 8th at
his home outside of London.
Jerry Benjamin's successful career began at Monsanto's healthcare and
petrochemical businesses, including a period as Director of Corporate
Venture Capital. He later joined Advent Venture Partners, serving as a
General Partner until his retirement. His many accomplishments there
included the successful development of Advent's investment activities in
the healthcare and medical sectors. After retirement, he continued his
involvement with Advent as an advisor to the Life Sciences team. Mr.
Benjamin served as a non-executive director of a number of companies,
including eighteen years on the Board of Orthofix International NV, most
recently as Chairman of the Audit Committee.
Jim Gero, Chairman of the Board of Directors stated, "Jerry Benjamin
served Orthofix faithfully throughout his tenure as a highly respected
Director, and contributed greatly to the company's success. He was a
friend for close to two decades, and will be dearly missed by all his
colleagues on the Board."
"Jerry was the quintessential gentleman and a man of impeccable
character," said Alan Milinazzo, Orthofix's Group President and CEO.
"His background in chemical engineering and biotechnology and investment
expertise provided a foundation upon which he amassed his legacy of
business success. As an Orthofix Director, his personal attributes of
loyalty, strong leadership, dedication and teamwork will be greatly
missed. He was a great friend and advisor."
The company extends its condolences to Mr. Benjamin's family, friends
and colleagues.
About Orthofix
Orthofix International, N.V. is a global medical device company offering
a broad line of minimally invasive surgical and non-surgical products
for the spine, orthopedic, and sports medicine market sectors, that
address the lifelong bone-and-joint health needs of patients of all ages
- helping them achieve a more active and mobile lifestyle. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
and via collaborations with other leading orthopedic product companies.
In addition, Orthofix is collaborating and investing in R&D activities
with leading medical institutions such as the Musculoskeletal Transplant
Foundation, the Orthopedic Research and Education Foundation, The
University of Medicine and Dentistry of New Jersey and the National
Osteoporosis Institute. For more information about Orthofix, please
visit www.orthofix.com.
Orthofix International N.V.
Brian McCollum, 214-937-2927
brianmccollum@orthofix.com
Source: Orthofix International NV
News Provided by Acquire Media